Diabetech - Diabetes Tech, Research, News

Why Some CGMs May Be Less Safe Than You Think

May 11, 2026·58 min
Episode Description from the Publisher

Continuous glucose monitors (CGMs) play a major role in diabetes management, but not all CGM accuracy and testing standards are the same. In this episode, I sit down with John Pemberton of Glucose Never Lies to break down how CGMs are tested, and why FDA clearance and CE marking aren’t equivalent when it comes to insulin dosing safety. As diabetes technology moves toward automated insulin delivery, we explore the risks of relying on data that may not be rigorously validated. We also cover the key questions every person with diabetes should ask before trusting their CGM.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Join the Diabetech Newsletter   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   Follow The Glucose Never Lies: Instagram | Youtube | LinkedIn   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of Diabetech - Diabetes Tech, Research, News and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.